TrisHCl (pH 8.0). The gradient was centrifuged (250.000 g, 30 min, 4 ºC, TLA100.4 rotor,Beckman Centrifuges) and the brownish cytoplasmic membrane fraction was collected from the 45% sucrose layer. The collected cytoplasmic membranes were diluted 5-fold with 50 mM TrisHCl, pH 8.0, and recollected by ultracentrifugation ((250.000 g, 30 min, 4 ºC, TLA100.4 rotor (Beckman Centrifuges)). The pellet was resuspended in 50 mM TrisHCl (pH 8.0), 20% (v/v) glycerol, frozen in liquid nitrogen, and stored at -80ºC. The F 1 F 0 -ATP ase was purified using a multiple column strategy alternating anion exchange with size exclusion chromatography. The with a 125 -300 mM KCl gradient [3] . The KCl gradient was run in10 column volumes at a flow rate of 1 mL/min and a collected fraction volume of 1 mL. The F 1 F 0 -ATPase complex containing fractions were identified by western blot analysis using specific antibodies against the beta-subunit (F 1 ) and the b-subunit (F 0 ) of the complex. Identified fractions were pooled and loaded onto an size exclusion chromatography column (HiPrep 26/60 Sephacryl S-300 HR, GE) previously equilibrated with 50 mM Tris-HCl (pH 8), 20 % (v/v) glycerol, 100 mM KC1, 0.05% (w/v) DDM at a flow rate of 0.5 mL/min to specifically separate the large F 1 F 0 -ATPase complex (~530 kDa) from other proteins present in the sample. Proteins were eluted from the column with the same buffer and the collected fractions and the F 1 F 0 -ATPase complex containing fraction were identified by western blot analysis. To concentrate the complex, the elution fractions collected were pooled and again loaded on a 5 mL HiTrap Q HP anion exchange column and eluted as described above.
Preparation of liposomes:
Liposomes were prepared by mixing phosphatidylcholine (PC, Avanti) and phosphatidic acid (PA, Avanti) in 9 PC: 1 PA proportion as reported in [4] , but without quinone addition.
Preparation of proteoliposomes:
In order to incorporate F 1 F 0 -ATPase in the liposomes a similar procedure to the one described in [4] was used. In this case 3.3 µL of an F 1 F 0 -ATPase solution of 0.5 mg/mL was added to 500 µL of 0.2 mg/mL liposome suspension.
Gold surface preparation: Au wires (0.5 mm diameter, Goodfellow) and Au-coated substrates
(1 × 1 cm 2 , Metallhander Schroer GMBH) were cleaned, annealed and chemically modified with 4-aminothiophenol (Sigma) as described in [4] . reported in [5] and in a second step F 1 F 0 -ATPase was immobilized as indicated above. A control experiment was done with covalently immobilized Hase and a PhBL formed on top of the Hase monolayer (Au/Hase/PhBL) as reported in [5] .
Enzyme immobilization on the
AFM Measurements: Characterization of the samples by AFM was made with a 5500 Agilent Technologies microscope. All samples were scanned at room temperature in 0.1M phosphate buffer solution using silicon nitride cantilevers (Olympus, RC800PSA). Images obtained were analysed using WSxM software from Nanotec Electrónica.
Quartz Crystal Microbalance (QCM) measurements:
QCM measurements using liposomes were performed with a 5 MHz SiO 2 quartz crystals from Q-Sense. Before each measurement SiO 2 -coated crystals were cleaned in a 2% (w/v) sodium dodecyl sulfate (SDS) solution for 15 min, rinsed extensively with distilled water, dried under a stream of nitrogen gas and exposed to a UV/ozone cleaner (Bioforce Nanoscience, model Electrochemical measurements: Electrochemical experiments were performed as described in [5] .
Inorganic phosphate determination: Inorganic phosphate (Pi) determination was performed by the Green Malachite assay [6] , in which 200 µL of sample were mixed with 800 µL of Green Malachite solution and the absorbance at 660 nm was measured in a spectrophotometer after 2 minutes incubation at room temperature.
ATP determination:
The Luciferase assay kit from Molecular Probes and a Luminometer were used for measuring ATP concentration.
